Sign In
to Vote &
Create Storyboards.
 
(Wyss Institute for Biologically Inspired Engineering at Harvard) Delivering mesenchymal stromal cells (MSCs) along with therapeutic stem cells has the potential to reduce host-vs-graft disease and transplant rejection, but MSCs have been plagued by high clearance from the body and immune attack. A new hydrogel-based encapsulation method developed at the Wyss Institute not only protects MSCs from immune attack and clearance, but dramatically improved the success of bone marrow transplants in mic...
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard